A PGA-gelatin composite material and its preparation method and application

By preparing PGA-gelatin composite materials, the problems of difficult control of pore shape in non-woven materials and the application of traditional scaffold materials in small-diameter blood vessel transplantation have been solved. High biocompatibility and bioactivity that can be degraded in natural conditions are achieved, making them suitable for tissue-engineered blood vessel culture and clinical projects.

CN115998951BActive Publication Date: 2024-11-12HUAJU (GUANGZHOU) BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310034575.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-01-10
Publication Date
2024-11-12
Estimated Expiration
2043-01-10

AI Technical Summary

Technical Problem

Existing tissue engineering nonwoven materials have difficulty controlling pore shape, and traditional scaffold materials have thrombosis and regeneration problems in small-diameter vascular transplantation, lacking effective solutions.

Method used

PGA-gelatin composite material is prepared by preparing a PGA solution, heating and mixing, cooling and 3D printing to form a non-woven sheet structure with gelatin evenly distributed in the material. PGA-gelatin composite material is prepared using fused filament manufacturing technology.

Benefits of technology

PGA-gelatin composite materials degrade naturally, with a degradation cycle that matches tissue-engineered blood vessel culture. They exhibit high biocompatibility and bioactivity, making them suitable for artificial tissue culture and clinical projects, and facilitating cell transplantation and inoculation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115998951B_ABST
    Figure CN115998951B_ABST
Patent Text Reader

Abstract

The present invention relates to the field of tissue engineering technology, and specifically discloses a PGA-gelatin composite material and a preparation method and application thereof, wherein the preparation method comprises the following steps: preparing a PGA solution; adding powdered gelatin to the PGA solution to obtain a mixed solution; heating the mixed solution to obtain a molten mixture; cooling the molten mixture to a printing temperature, and performing 3D printing according to a cross-diamond shape to generate a PGA-gelatin composite material; the PGA-gelatin composite material prepared by the preparation method can be degraded in a natural state, and the degradation cycle is highly consistent with tissue engineering blood vessel culture, and gelatin is evenly distributed on the material, and has the characteristics of high biological compatibility and high biological activity, and is suitable for use in various artificial tissue cultures or clinical projects, and the PGA-gelatin composite material is in a non-woven sheet structure as a whole, which is convenient for transplantation or inoculation of cells.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of tissue engineering technology, and in particular to a PGA-gelatin composite material and a preparation method and application thereof. Background Art

[0002] The mortality rate caused by cardiovascular diseases is still on the rise, but there are still many bottlenecks in the application of small-caliber blood vessels. For example, traditional stent material transplantation cannot effectively solve problems such as thrombosis and regeneration.

[0003] Studies have shown that non-woven materials have a more suitable pore size for the growth of smooth muscle cells, but the pore shape of existing non-woven materials used in tissue engineering is difficult to control and requires certain conditions for degradation.

[0004] There is currently no effective technical solution to the above problems. Summary of the invention

[0005] The purpose of the present application is to provide a PGA-gelatin composite material and a preparation method and application thereof, so as to obtain a porous inoculation material that can be naturally degraded and is suitable for use in various types of artificial tissue culture.

[0006] In a first aspect, the present application provides a method for preparing a PGA-gelatin composite material, the method comprising the following steps:

[0007] S1. Prepare PGA solution;

[0008] S2, adding powdered gelatin to the PGA solution to obtain a mixed solution;

[0009] S3, heating the mixed solution to obtain a molten mixture;

[0010] S4. Cooling the molten mixture to a printing temperature and performing 3D printing according to a cross-diamond shape to generate a PGA-gelatin composite material.

[0011] The preparation method of the PGA-gelatin composite material of the present application is based on heating a PGA solution mixed with gelatin to obtain a molten mixture, and extruding the molten mixture through 3D printing to form a PGA-gelatin composite material with a non-woven sheet structure. The preparation process is simple and convenient; the PGA-gelatin composite material can be degraded under natural conditions, and the degradation cycle is highly consistent with tissue engineering vascular culture. At the same time, gelatin is evenly distributed on the material, and it has the characteristics of high biological compatibility and high biological activity. It is suitable for use in various artificial tissue cultures or clinical projects, and the PGA-gelatin composite material has a non-woven sheet structure as a whole, which is convenient for transplantation or cell inoculation.

[0012] The preparation method of the PGA-gelatin composite material, wherein the PGA solution is prepared based on PGA molecules with a molecular weight of 100kDa and a diameter of 5-20um.

[0013] In this example, the PGA molecule can ensure that the PGA-gelatin composite material is printed smoothly and that the gelatin used for tissue culture is evenly distributed in the composite material, so that the PGA-gelatin composite material can provide high-purity, easily absorbed, and burden-free high-quality collagen during the application process.

[0014] The method for preparing the PGA-gelatin composite material, wherein the mass fraction of gelatin in the mixed solution is 1%-10% and the molecular weight is 0.5-10kDa.

[0015] In the method for preparing the PGA-gelatin composite material, the heating temperature in step S3 is 220-225°C.

[0016] The method for preparing the PGA-gelatin composite material, wherein the step between step S3 and step S4 further includes the following steps:

[0017] S3', keeping the molten mixture warm for 5-10 minutes.

[0018] The method for preparing the PGA-gelatin composite material, wherein the printing temperature is 60-100°C.

[0019] The preparation method of the PGA-gelatin composite material, wherein the 3D printing is based on a printing needle diameter of 50-200um, a printing pressure of 8-10bar and a 0.5-1.5mm s -1 Print at the print speed.

[0020] In a second aspect, the present application further provides a PGA-gelatin composite material, which is prepared based on the preparation method of the PGA-gelatin composite material provided in the first aspect.

[0021] The PGA-gelatin composite material of the present application can be degraded in a natural state, and the degradation cycle is highly consistent with tissue engineering vascular culture. At the same time, gelatin is evenly distributed on the material, and it has the characteristics of high biological compatibility and high biological activity. It is suitable for use in various artificial tissue cultures or clinical projects. The PGA-gelatin composite material has a non-woven sheet structure as a whole, which is convenient for transplantation or cell inoculation.

[0022] In a third aspect, the present application also provides the use of the PGA-gelatin composite material provided in the first aspect in tissue engineering blood vessel culture.

[0023] The natural degradation cycle of the PGA-gelatin composite material of the present application is similar to that of the composite material, which is highly suitable for use in tissue engineering vascular culture. The gelatin is attached to the PGA molecules, which makes the PGA-gelatin composite material have excellent biological compatibility and biological activity, so that vascular smooth muscle cells can be successfully inoculated on its surface for static and dynamic culture.

[0024] In a fourth aspect, the present application also provides the use of the PGA-gelatin composite material provided in the first aspect in postage stamp grafting.

[0025] The PGA-gelatin composite material of the present application can be naturally degraded, which saves the operator from the pain of removing the oil gauze in the later stage, and is beneficial to the survival of the skin graft. In addition, the PGA-gelatin composite material has pores, which is conducive to cell growth.

[0026] As can be seen from the above, the present application provides a PGA-gelatin composite material and its preparation method and application, wherein the preparation method is based on heating a PGA solution mixed with gelatin to obtain a molten mixture, and extruding the molten mixture through 3D printing to form a PGA-gelatin composite material with a non-woven sheet structure, and the preparation process is simple and convenient; the PGA-gelatin composite material can be degraded under natural conditions, and the degradation cycle is highly consistent with tissue engineering vascular culture, and at the same time, gelatin is evenly distributed on the material, and it has the characteristics of high biological compatibility and high biological activity, and is suitable for use in various types of artificial tissue culture or clinical projects, and the PGA-gelatin composite material has a non-woven sheet structure as a whole, which is convenient for transplantation or inoculation of cells. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 This is a flow chart of the method for preparing the PGA-gelatin composite material provided in an embodiment of the present application.

[0028] Figure 2 This is a schematic diagram of the enlarged structure of the cross diamond of the PGA-gelatin composite material provided in the examples of the present application.

[0029] Figure 3 This is a schematic diagram of the structure of the PGA-gelatin composite material provided in the examples of the present application. DETAILED DESCRIPTION

[0030] The technical solutions in the embodiments of the present application will be clearly and completely described below in conjunction with the drawings in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, rather than all of the embodiments. Therefore, the following detailed description of the embodiments of the present application provided in the drawings is not intended to limit the scope of the application claimed for protection, but merely represents the selected embodiments of the present application. Based on the embodiments of the present application, all other embodiments obtained by those skilled in the art without making creative work belong to the scope of protection of the present application.

[0031] First, please refer to Figure 1 Some embodiments of the present application provide a method for preparing a PGA-gelatin composite material, the method comprising the following steps:

[0032] S1. Prepare PGA solution;

[0033] S2, adding powdered gelatin to the PGA solution to obtain a mixed solution;

[0034] S3, heating the mixed solution to obtain a molten mixture;

[0035] S4, cooling the molten mixture to a printing temperature and performing 3D printing according to a cross-diamond shape to generate a PGA-gelatin composite material.

[0036] Specifically, PGA (Polyglycolic acid) is a synthetic polymer material with good biodegradability and biocompatibility. Unlike traditional polymer materials with stable performance, such as plastics and rubber, polyglycolic acid as a material gradually degrades after a certain period of use, and eventually turns into water and carbon dioxide that are harmless to the human body, animals, plants and the natural environment. Compared with other polymer materials such as PLA (polylactic acid) commonly used in tissue engineering, PGA does not require special conditions for its degradation process and can be degraded in a natural environment. It is an ideal completely biodegradable material with a degradation cycle of 1-3 months, which is highly consistent with the cycle of tissue engineering blood vessel culture. Therefore, the PGA-gelatin composite material prepared by the method of the embodiment of the present application uses PGA instead of polymer materials such as PLA as a matrix, so that the prepared PGA-gelatin composite material can be more suitable for tissue engineering blood vessel culture.

[0037] More specifically, gelatin is mainly composed of a protein with a three-dimensional helical structure and has good biological compatibility, biodegradability and biological activity. The method of the embodiment of the present application mixes gelatin in a PGA solution, so that the prepared PGA-gelatin composite material has gelatin evenly distributed inside and outside, thereby improving the biological compatibility of the PGA-gelatin composite material. When the composite material is used in tissue engineering blood vessel culture, the evenly distributed gelatin can also increase the biological activity of the seed cells adhered to the composite material, thereby promoting tissue engineering blood vessel culture.

[0038] More specifically, PGA is insoluble in most organic solvents, but is soluble in highly fluorinated, highly polar solvents, so hexafluoroisopropanol (HFIP) or fluoroacetone-based dopa can be used as a solvent to prepare a PGA solution; adding powdered gelatin to the PGA solution in step S2 can evenly disperse the gelatin in the PGA solution, so that the gelatin in the subsequently prepared PGA-gelatin composite material is evenly dispersed on the PGA.

[0039] More specifically, the method of the embodiment of the present application is equivalent to 3D printing based on hot extrusion, that is, fused filament fabrication (FFF) is performed using a molten mixture containing PGA and gelatin, so that the molten filaments composed of PGA and gelatin are printed along a cross-rhombus shape to generate a PGA-gelatin composite material, so that the PGA-gelatin composite material forms a non-woven sheet structure, and the printing temperature during the 3D printing process should be higher than the glass transition temperature of the PGA material to ensure that the molten mixture can be smoothly extruded and printed; it should be noted that in the process of heating to obtain the molten mixture in step S3, the solvent in the PGA solution is evaporated, so that the molten mixture only contains evenly mixed PGA and gelatin.

[0040] More specifically, fused filament fabrication (FFF) is one of the 3D printing technologies for thermoplastic polymers. It uses a computer-controlled nozzle to scan in conjunction along a specific path to extrude molten filaments to form a spatial entity to achieve 3D printing, which can be used to form various three-dimensional geometric shapes. In the method of the embodiment of the present application, step S4 is based on the 3D printing principle of fused filament fabrication, and molten filaments are produced by extruding the molten mixture prepared in step S3. The nozzle is moved and the molten mixture is extruded based on a cross diamond shape only in the XY plane to form a PGA-gelatin composite material with a non-woven sheet structure. A PGA-gelatin composite material with a two-dimensional structure (non-woven sheet structure) is prepared using fused filament fabrication technology that can form various three-dimensional geometric shapes. It should be noted that after completing the printing of one print layer, a new PGA-gelatin composite material can be superimposed and printed thereon, so that the thickness of the non-woven sheet structure of the PGA-gelatin composite material finally obtained meets the usage requirements.

[0041] More specifically, if Figure 2 As shown, the cross-diamond-shaped PGA-gelatin composite material is a filamentary matrix made of PGA as a molten filament, and the black dots are gelatin, which are evenly distributed on the PGA filamentary matrix to form a printing unit of the PGA-gelatin composite material; Figure 3 As shown (black dots are hidden), the PGA-gelatin composite material as a whole is a non-woven sheet structure in the shape of a cross rhombus. The size of the rhombus structure determines the pores of the non-woven fabric, and at the same time makes the PGA-gelatin composite material have evenly distributed pores of uniform size; in an embodiment of the present application, PGA-gelatin composite materials with different pore sizes can be generated by changing the side length of the cross rhombus during the 3D printing process.

[0042] The preparation method of the PGA-gelatin composite material in the embodiment of the present application is based on heating a PGA solution mixed with gelatin to obtain a molten mixture, and extruding the molten mixture through 3D printing to form a PGA-gelatin composite material with a non-woven sheet structure. The preparation process is simple and convenient; the PGA-gelatin composite material can be degraded under natural conditions, and the degradation cycle is highly consistent with tissue engineering vascular culture. At the same time, gelatin is evenly distributed on the material, and it has the characteristics of high biological compatibility and high biological activity. It is suitable for use in various artificial tissue cultures or clinical projects, and the PGA-gelatin composite material has a non-woven sheet structure as a whole, which is convenient for transplantation or cell inoculation.

[0043] In some preferred embodiments, the PGA solution is formulated based on PGA molecules with a molecular weight of 100 kDa and a diameter of 5-20 um.

[0044] Specifically, the molecular weight distribution range of gelatin is relatively large. In order to make the final prepared PGA-gelatin composite material a composite material made of PGA as a matrix and gelatin as a uniformly distributed additional material, it is necessary to use PGA molecules with a larger molecular weight to prepare the PGA solution, and the diameter of the 3D printing needle must be considered to determine the diameter of the PGA; therefore, in the embodiment of the present application, the molecular weight of the PGA molecule is greater than 10 times the molecular weight of the added gelatin, and the molecular diameter of the PGA is less than half the diameter of the printing needle; PGA molecules with a molecular weight of 100kDa and a diameter of 5-20um can effectively meet the above requirements, ensure that the PGA-gelatin composite material is printed smoothly and ensure that the gelatin used for tissue culture can be evenly distributed in the composite material, so that the PGA-gelatin composite material can provide high-purity, easily absorbed, and burden-free high-quality collagen during the application process.

[0045] In some preferred embodiments, the mass fraction of gelatin in the mixed solution is 1%-10%, and the molecular weight is 0.5-10 kDa.

[0046] Specifically, in order to ensure that gelatin can be evenly distributed in the PGA-gelatin composite material and avoid excessive gelatin affecting the molten wire manufacturing process, the molecular weight of the gelatin added to the PGA solution in step S2 is 0.5-10kDa, and the added amount is 1%-10% of the mass fraction of the mixed solution. Gelatin of this molecular weight is suitable for tissue culture use, and the total amount of PGA will not affect the molten wire production of PGA.

[0047] More specifically, it should be noted that the gelatin in the PGA-gelatin composite material is evenly distributed on the surface of the PGA molecules, thereby improving the biological activity and biological compatibility of the surface of the PGA-gelatin composite material, thereby making the surface of the PGA molecules suitable for cell survival, so that the prepared PGA-gelatin composite material can be applied to tissue culture and clinical projects.

[0048] In some preferred embodiments, the heating temperature in step S3 is 220-225°C.

[0049] Specifically, the melting point of common PGA molecules is generally between 200-220°C. Step S3 sets the heating temperature to 220-225°C to convert PGA into a molten state and mix it with gelatin to form a molten mixture, so that gelatin can evenly adhere to the surface of the PGA molecules in the molten state.

[0050] In some preferred embodiments, the step S3 and the step S4 further include the following steps:

[0051] S3', keep the molten mixture warm for 5-10 minutes.

[0052] Specifically, in order to ensure that PGA can be effectively heated to a molten state, the molten mixture needs to be kept warm for a short time so that gelatin can be evenly distributed on the surface of the molten PGA molecules.

[0053] More specifically, in addition, since the thermal degradation temperature of PGA is 230-250°C, PGA molecules may undergo intramolecular ester exchange degradation starting from the melting point temperature, so the insulation time should be set shorter. In the embodiment of the present application, it is preferably set to 5-10 minutes.

[0054] In some preferred embodiments, the printing temperature is 60-100°C.

[0055] Specifically, the glass transition temperature of PGA (the transition of an amorphous substance between a glassy state and a highly elastic state) is 35-40°C, but it will change to a certain extent after mixing with gelatin. If 3D printing is performed directly at a temperature slightly higher than the glass transition temperature of PGA, it is easy to cause the molten mixture to crystallize and block the printing needle, resulting in printing failure. Therefore, it is necessary to redetermine the printing temperature of the molten mixture; in an embodiment of the present application, differential scanning calorimetry-modulated differential scanning calorimetry (mDSC) is used to measure the printing temperature, that is, a differential scanning calorimeter (TA DSC Q100, TA Instruments, New Castle, DE) is used to obtain the glass transition and thermal energy change relationship between PGA and gelatin (whose components correspond to the molten mixture) as a function of temperature change to determine the glass transition temperature of the molten mixture, and then set the printing temperature; based on the above measurement method, the method of the embodiment of the present application determines the printing temperature to be 60-100°C to ensure that the molten mixture can be smoothly extruded for 3D printing to prepare a PGA-gelatin composite material.

[0056] More specifically, step S4 is a process of cooling the molten mixture to the printing temperature: quickly cooling the molten mixture from a state of 220-225°C to 60-100°C; it should be noted that the crystallization temperature of PGA molecules is 160-200°C, therefore, the crystallization morphology of PGA molecules is not a normal spherulite, but a relatively complex polygonal crystal, and the nucleation density of PGA increases with the increase of molecular weight. During the crystallization process of PGA molecules, gelatin adheres to its surface due to the viscosity of PGA molecules.

[0057] More specifically, the half-crystallization time of PGA increases with the increase of crystallization temperature. In the embodiment of the present application, step S4 is cooled at a rate of 10-20°C / min to quickly cool the molten mixture to 60-100°C to shorten the half-crystallization time of PGA before 3D printing.

[0058] In some preferred embodiments, 3D printing is based on a printing pin diameter of 50-200 um, a printing pressure of 8-10 bar, and a printing speed of 0.5-1.5 mm s -1 Print at the print speed.

[0059] Specifically, the diameter of the PGA molecules in the PGA-gelatin composite material prepared by the method of the embodiment of the present application is in the range of 5-20 um, so a printing needle with a diameter of 50-200 um can be used to smoothly extrude a mixture of PGA molecules and gelatin molecules.

[0060] More specifically, the method of the embodiment of the present application is based on a printing pressure of 8-10 bar and a printing speed of 0.5-1.5 mm s -1 3D printing at a printing speed of can smoothly extrude the mixture of PGA and gelatin to obtain a PGA-gelatin composite material with a non-woven sheet structure of uniform thickness.

[0061] More specifically, in an embodiment of the present application, the 3D printing process is a process of moving the nozzle based on a cross-rhombus shape in the XY plane and extruding to generate a PGA-gelatin composite material. The pore size of the non-woven sheet structure can be changed by changing the side length of the cross-rhombus, thereby obtaining a PGA-gelatin composite material with a pore size range of 300-500 um, 100-300 um, 50-100 um, etc., and the side length of the cross-rhombus can be dynamically adjusted during the 3D printing process to obtain a PGA-gelatin composite material with a non-woven sheet structure having different pore distribution characteristics, such as the pore size varies from 300-500 um, 100-300 um, and 50-100 um from the edge to the middle of the non-woven sheet structure. The side length of the cross-rhombus of each printing layer can also be dynamically adjusted during the 3D printing process to obtain a PGA-gelatin composite material with a non-woven sheet structure having different pore distribution characteristics.

[0062] In some preferred embodiments, the PGA-gelatin composite material prepared by the method of the examples of the present application is a square non-woven sheet structure with a thickness of 0.1-0.12 cm and a side length of 6 cm.

[0063] The preparation process of the PGA-gelatin composite material in the embodiment of the present application is more clearly described below in combination with the preparation methods of different embodiments:

[0064] Example 1

[0065] The preparation method of the PGA-gelatin composite material comprises the following steps:

[0066] A1. Prepare a PGA solution based on a PGA molecule with a molecular weight of 100 kDa and a diameter of 10 um;

[0067] A2, adding powdered gelatin to the PGA solution to obtain a mixed solution, wherein the mass fraction of gelatin in the mixed solution is 5% and the molecular weight is 5 kDa;

[0068] A3, heating the mixed solution to 223° C. to obtain a molten mixture, and keeping the molten mixture warm for 7 minutes;

[0069] A4. Cooling at a rate of 15°C / min to quickly cool the molten mixture to 80°C to obtain a mixture to be printed;

[0070] A5, based on 125um print pin diameter, 9bar print pressure and 1mm s -1 The mixture was printed at a printing speed of 100 Å to produce a PGA-gelatin composite material.

[0071] Example 2

[0072] B1. Prepare a PGA solution based on a PGA molecule with a molecular weight of 100 kDa and a diameter of 5 um;

[0073] B2, adding powdered gelatin to the PGA solution to obtain a mixed solution, wherein the mass fraction of gelatin in the mixed solution is 1% and the molecular weight is 0.5 kDa;

[0074] B3, heating the mixed solution to 220° C. to obtain a molten mixture, and keeping the molten mixture warm for 5 minutes;

[0075] B4, cooling at a rate of 20°C / min to quickly cool the molten mixture to 60°C to obtain a mixture to be printed;

[0076] B5, based on 50um print pin diameter, 8bar print pressure and 0.5mm s -1 The mixture was printed at a printing speed of 100 Å to produce a PGA-gelatin composite material.

[0077] Example 3

[0078] C1. Prepare a PGA solution based on a PGA molecule with a molecular weight of 100 kDa and a diameter of 20 um;

[0079] C2, adding powdered gelatin to the PGA solution to obtain a mixed solution, wherein the mass fraction of gelatin in the mixed solution is 10% and the molecular weight is 10 kDa;

[0080] C3. Heat the mixed solution to 225°C to obtain a molten mixture, and keep the molten mixture warm for 10 minutes.

[0081] C4, cooling at a rate of 10°C / min to rapidly cool the molten mixture to 100°C to obtain the mixture to be printed,

[0082] C5, based on 200um print pin diameter, 10bar print pressure and 1.5mm s -1 The mixture was printed at a printing speed of 100 Å to produce a PGA-gelatin composite material.

[0083] Second, please refer to Figure 2 and Figure 3 Some embodiments of the present application also provide a PGA-gelatin composite material, which is prepared based on the preparation method of the PGA-gelatin composite material provided in the first aspect.

[0084] The PGA-gelatin composite material of the embodiment of the present application can be degraded in a natural state, and the degradation cycle is highly consistent with tissue engineering vascular culture. At the same time, gelatin is evenly distributed on the material, and it has the characteristics of high biological compatibility and high biological activity. It is suitable for use in various artificial tissue cultures or clinical projects. The PGA-gelatin composite material has a non-woven sheet structure as a whole, which is convenient for transplantation or cell inoculation.

[0085] Application Example 1

[0086] The PGA-gelatin composite material provided in the embodiments of the present application can be applied in tissue engineering blood vessel culture, and the application process of some embodiments thereof is as follows:

[0087] D1. A PGA-gelatin composite material having a non-woven fabric sheet structure with a thickness of 0.1 cm and a length of 6 cm was prepared based on the method of the embodiment of the present application;

[0088] D2, placing the PGA-gelatin composite material in a NaOH solution with a pH value of 10 and soaking it for 1-2 minutes;

[0089] D3, taking out the soaked PGA-gelatin composite material, and placing it in a sterile biosafety cabinet for ventilation overnight to dry, and disinfecting it with ultraviolet light;

[0090] D4, the dried and sterilized PGA-gelatin composite material was seamlessly sutured to the silicone tube of the corresponding caliber used for tissue engineering blood vessel culture, and 6 -10 7 Vascular smooth muscle cells were seeded on the PGA-gelatin composite material at a cell density of 100 cells / L;

[0091] D5. The PGA-gelatin composite material seeded with vascular smooth muscle cells was statically cultured for two weeks without a peristaltic pump and under corresponding culture conditions;

[0092] D6. Under the conditions of a peristaltic pump and corresponding culture conditions, the PGA-gelatin composite material inoculated with vascular smooth muscle cells was dynamically cultured for six weeks. When the PGA-gelatin composite material was degraded by 80-90%, a tissue engineering vascular scaffold material was obtained.

[0093] Specifically, in the above-mentioned embodiment, the culture cycle of tissue engineering blood vessel culture is approximately eight weeks, and the natural degradation cycle of the PGA-gelatin composite material of the embodiment of the present application is similar thereto, which is highly suitable for use in tissue engineering blood vessel culture. In addition, gelatin is attached to the PGA molecules, so that the PGA-gelatin composite material has excellent biological compatibility and biological activity, so that vascular smooth muscle cells can be successfully inoculated on its surface for static and dynamic culture.

[0094] Application Example 2

[0095] The PGA-gelatin composite material provided in the embodiments of the present application can be used in stamp grafting, and the application process of some embodiments thereof is as follows:

[0096] E1. Preparing a dried and sterilized PGA-gelatin composite material based on steps D1 to D3;

[0097] E2. Use the dried and sterilized PGA-gelatin composite material to cover the stamp skin graft. Depending on the use requirements, choose to mix or not mix the patient's own PRP (platelet-rich plasma), serum and other nutrients to cover the surface of the stamp skin graft;

[0098] E3. Regularly increase the local oxygen and nutrient supply to the skin graft.

[0099] Specifically, in the above embodiment, compared with the existing oil gauze covering treatment method, the PGA-gelatin composite material can degrade naturally, eliminating the pain of the surgeon in the later removal of the oil gauze, and is beneficial to the survival of the skin graft. The PGA-gelatin composite material has pores, which is conducive to cell growth.

[0100] In summary, the embodiments of the present application provide a PGA-gelatin composite material and a preparation method and application thereof, wherein the preparation method is based on heating a PGA solution mixed with gelatin to obtain a molten mixture, and extruding the molten mixture through 3D printing to form a PGA-gelatin composite material with a non-woven sheet structure, and the preparation process is simple and convenient; the PGA-gelatin composite material can be degraded under natural conditions, and the degradation cycle is highly consistent with tissue engineering vascular culture, and at the same time, gelatin is evenly distributed on the material, and it has the characteristics of high biological compatibility and high biological activity, and is suitable for use in various types of artificial tissue culture or clinical projects, and the PGA-gelatin composite material has a non-woven sheet structure as a whole, which is convenient for transplantation or inoculation of cells.

[0101] The above description is only an embodiment of the present application and is not intended to limit the protection scope of the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.

Claims

1. A method for preparing a PGA-gelatin composite material, characterized in that: The method comprises the following steps: S1. preparing a PGA solution, wherein the PGA solution is prepared based on PGA molecules with a molecular weight of 100 kDa and a diameter of 5-20 um; S2, adding powdered gelatin to the PGA solution to obtain a mixed solution, wherein the mass fraction of gelatin in the mixed solution is 1%-10% and the molecular weight is 0.5-10 kDa; S3, heating the mixed solution to obtain a molten mixture, the heating temperature being 220-225° C.; S4, cooling the molten mixture to a printing temperature, and performing 3D printing according to a cross-diamond shape to generate a PGA-gelatin composite material, wherein the 3D printing is based on a printing needle diameter of 50-200 um, a printing pressure of 8-10 bar, and a printing pressure of 0.5-1.5 mms -1 Print at the printing speed; The steps between step S3 and step S4 include: S3', keeping the molten mixture warm for 5-10 minutes; The step of cooling the molten mixture to a printing temperature comprises: Cooling at a rate of 10-20°C / min to rapidly cool the molten mixture to 60-100°C; The molecular weight of PGA in the PGA solution is greater than 10 times the molecular weight of the added gelatin, and the molecular diameter of the PGA is less than half the diameter of the printing needle of 3D printing.

2. A PGA-gelatin composite material, characterized in that: It is prepared based on the preparation method of the PGA-gelatin composite material as described in claim 1.

3. Use of the PGA-gelatin composite material as claimed in claim 2 in the preparation of stamp grafts.